Relay Therapeutics, Inc.
RLAY
$10.69
$0.555.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.13% | 13.79% | 3.49% | -1.30% | 1.25% |
| Total Depreciation and Amortization | -34.90% | -22.03% | -10.73% | -3.48% | 3.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.30% | -4.22% | 5.00% | -10.39% | -0.48% |
| Change in Net Operating Assets | -259.41% | -156.30% | 18.80% | 73.54% | 145.04% |
| Cash from Operations | 5.48% | 11.40% | 6.88% | 4.06% | 17.05% |
| Capital Expenditure | 79.68% | 80.85% | 74.51% | 84.41% | 51.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 594.58% | 2,358.90% | -88.88% | -104.33% | -114.92% |
| Cash from Investing | 569.29% | 1,891.16% | -89.07% | -104.74% | -115.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.41% | -99.50% | 169.24% | 168.56% | 677.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.41% | -99.50% | 169.24% | 168.56% | 677.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -104.88% | -13,853.74% | -75.20% | -623.57% | -152.71% |